Cat. No. | Product Name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T10905 | CXCR2-IN-1
化合物CXCR2-IN-1
|
1873376-49-8 | 98% |
![]() |
CXCR2-IN-1是可渗透中枢神经系统的 CXCR2拮抗剂,pIC50值为9.3。 | ||||
T68052 | Delmetacin
地美辛
|
16401-80-2 | 98% |
![]() |
Delmetacin 是一种非甾体抗炎化合物,具有抗炎和镇痛活性,对 CXC 趋化因子受体 CXCR1 具有抑制作用。 | ||||
T25131 | AZD8309
化合物AZD8309
|
333742-48-6 | 98% |
![]() |
AZD8309 是一种强效的、可口服的趋化因子受体CXCR2的拮抗剂, 能够调节中性粒细胞的转运,可显著降低胰腺和肺部的MPO,并降低胰腺内的胰蛋白酶和弹性蛋白酶活性。AZD8309 能够用于研究炎症系列疾病。 | ||||
T10635 | Burixafor hydrobromide
化合物 T10635
|
1191450-19-7 | 98% |
![]() |
Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent CXCR4 antagonist and an anti-angiogenic drug that is of potential value in tre... | ||||
T11140 | E6130
化合物 T11140
|
1427058-33-0 | 98% |
![]() |
E6130 may be effective in the treatment of inflammatory bowel disease and is a highly selective CX3CR1 regulator for oral administration. | ||||
T16933 | SRT3190
化合物 T16933
|
1204707-73-2 | 98% |
![]() |
SRT3190 is an antagonist of CXCR2. | ||||
T12269L | NUCC-390 dihydrochloride (1060524-97-1 free base)
化合物 T12269L
|
T12269L | 98% |
![]() |
NUCC-390 dihydrochloride is selective agonist of small-molecule CXCR4 receptor. | ||||
TN5227 | (+/-)-Vestitol
化合物 TN5227
|
56701-24-7 | 98% |
|
Vestitol has antioxidation, anti-inflammatory and antimicrobial activities, it can strongly act in a low dose and concentration and have a promising potential to... | ||||
T16864 | SCH 563705
化合物 T16864
|
473728-58-4 | 98% |
![]() |
SCH 563705 is an effective and orally available CXCR2 and CXCR1 antagonist (IC50s: 1.3 nM, 7.3 nM and Kis of 1 and 3 nM, respectively). | ||||
T19386 | ITIC
化合物 T19386
|
1664293-06-4 | 98% |
![]() |
ITIC, a non-fullerene acceptor, demonstrates exceptional thermal stability and exhibits a glass-crystal transition at a significantly lower temperature than its ... | ||||
T6764 | ATI-2341
化合物ATI-2341
|
1337878-62-2 | 98% |
![]() |
ATI2341 是 C-X-C 趋化因子受体 4 型功能选择性变构激动剂,作为偏向配体有利于 Gα1 激活。它是一种变构激动剂,可激活抑制性异源三聚体 G 蛋白 (Gi) 以促进抑制 cAMP 产生并诱导钙动员。 | ||||
T19385 | ITIC-4F
化合物 T19385
|
2097998-59-7 | 98% |
![]() |
ITIC-4F, an indacenodithienothiophene (IDTT)-based postfullerene electron acceptor, exhibits wide applicability in high-efficiency binary and ternary single-junc... | ||||
TP2141 | Balixafortide TFA (1051366-32-5 free base)
化合物 TP2141
|
TP2141 | 98% |
|
Balixafortide TFA (POL6326 TFA) is a selective, well-tolerated peptidic CXCR4 antagonist (IC50 < 10 nM). It shows 1000-fold selective for CXCR4 than a large pane... | ||||
T14665 | Motixafortide
化合物 T14665
|
664334-36-5 | 98% |
![]() |
Motixafortide (BKT140 4-fluorobenzoyl) is an antagonist of CXCR4 (IC50: 1 nM). | ||||
TP2141L | Balixafortide
化合物 TP2141L
|
1051366-32-5 | 98% |
|
Balixafortide (POL6326) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM and it is also a potent hematopoietic stem and prog... | ||||
T0801 | Tannic acid
单宁酸
|
1401-55-4 | 98% |
![]() |
Tannic acid 是新型hERG 通道阻塞剂,IC50为 3.4 μM。 | ||||
T1739 | WZ811
化合物WZ811
|
55778-02-4 | 98% |
![]() |
WZ811 是可口服的高竞争性CXCR4拮抗剂,抑制细胞中 CXCR4/SDF-1 介导的 cAMP 水平调节和 SDF-1 诱导的基质胶侵入,EC50为 1.2 和 5.2 nM。 | ||||
T3047 | SRT3109
化合物SRT3109
|
1204707-71-0 | 98% |
![]() |
SRT3109 是 CXCR2拮抗剂,pIC50值为 8.2,可用于趋化因子介导的疾病研究。 | ||||
T0617 | Nicotinamide N-oxide
烟酰胺-N-氧化物
|
1986-81-8 | 98% |
![]() |
Nicotinamide N-oxide 是生物体内烟酰胺分解代谢物,是高效选择性CXCR2受体拮抗剂。 | ||||
T10297L | AMG 487
化合物AMG 487
|
473719-41-4 | 98% |
![]() |
AMG 487 是可口服的选择性趋化因子受体3拮抗剂,对 I-IP-10、I-ITAC 和 MIG 的 IC50 值分别为 8、15 和 36nM。 |